Decheng Capital Management III »

Pyxis Oncology shares owned by Decheng Capital Management III

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Decheng Capital Management III from 13F filings

Historical chart of Decheng Capital Management III investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Decheng Capital Management III consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Decheng Capital Management III

Quarter filed Position value Share count Share price at filing
2023-09-30 $650k 327k 1.99

More positions owned by Decheng Capital Management III

Alpine Immune Sciences (ALPN)
Zentalis Pharmaceuticals (ZNTL)
Aura Biosciences (AURA)
Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV)
Acelyrin (SLRN)
Arcus Biosciences Incorporated (RCUS)
10x Genomics Cl A Com (TXG)
Argenx SE SHS (ARGX)
Pacific Biosciences of California (PACB)
Illumina (ILMN)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Horizon Therapeutics
Phathom Pharmaceuticals (PHAT)
ImmunoGen
Seagen

View all positions for Decheng Capital Management III

Top funds holding Pyxis Oncology

Laurion Capital Management
Balyasny Asset Management
Ikarian Capital
Vanguard Group
Standard Life Aberdeen
Millennium Management
Superstring Capital Management
Boothbay Fund Management
Monashee Investment Management
Hillhouse Capital Advisors
Geode Capital Management
Goldman Sachs Group
Decheng Capital
BlackRock
Bridgeway Capital Management

View all funds holding Pyxis Oncology